CEO Update - January 2017
We are pleased to announce the appointment of James R. Donnelly as Senior. Vice President of Sales & Marketing for CurAegis™. Mr. Donnelly has extensive experience in wearable technologies as well as start-ups. He is responsible for creating sales and marketing plans, sales processes and supporting the sales vice presidents in each of our identified vertical market opportunities. We are very excited about working with Jim. His abilities and experience match up perfectly to implement and accelerate our sales initiatives.
Additionally, we have added two important and prestigious members to our CURA™ Scientific Advisory Board: Dr. Michael Grandner from the Sleep and Health Research Program at the University of Arizona and Dr. Torbjorn Akerstedt from the Stress Research Institute at Stockholm University in Sweden. Dr. Grandner is the Director of and an Assistant Professor in the Department of Psychiatry at the University of Arizona College of Medicine. Dr. Grandner’s research focuses on how sleep and sleep-related behaviors are related to cardiovascular disease, diabetes, obesity, neurocognitive functioning, mental health, and longevity. A native to Sweden, Dr. Akerstedt is one of, if not the most, preeminent researcher in the area of fatigue management in the world. He has developed one of the gold standard tests (the “KSS test”) used for sleep and fatigue analysis. I believe that Dr. Akerstedt will be instrumental as we expand to international markets. Dr. Grandner and Dr. Akerstedt are highly respected experts in the field of Fatigue and Sleep Management and we are very proud and excited for them to join our Scientific Advisory Board. Their CVs are included on our website.
We have extended our internal beta testing to allow for further software refinement which we believe is not unusual in this type of technology. We anticipate the launch of our external beta phase the week of January 30, 2017.
As always, we are grateful for your patience and understanding through the years and hope we will justify both.
Richard A. Kaplan
Chief Executive Officer